Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.38 |
| ▸ | ARG2 | P78540 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | ACLY | P53396 | 11/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19990141 | 0.86 | KDM4E (0.42) | ACACBACACAGPR84FFAR1FFAR4 | |
| SCHEMBL851735 | 0.86 | KDM4E (0.42) | ACACBACACAGPR84FFAR1FFAR4 | |
| SCHEMBL3377620 | 0.79 | ACACB (0.39) | ACACBACACAARG2GPR84FFAR1 | |
| SCHEMBL7155871 | 0.76 | ALDH1A1 (0.39) | ACLYALDH1A1 | |
| SCHEMBL7149057 | 0.76 | ALDH1A1 (0.39) | ACLYALDH1A1 | |
| SCHEMBL10585526 | 0.76 | ALDH1A1 (0.39) | ACLYALDH1A1 | |
| SCHEMBL2925909 | 0.73 | LMNA (0.52) | CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL5574499 | 0.73 | LMNA (0.52) | CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL5574494 | 0.73 | LMNA (0.52) | CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL2925910 | 0.73 | LMNA (0.52) | CYP4F2CYP4A11ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2347753-B1 | Oral and tooth care and cleaning agents with alkylpyridine salts II | HENKEL AG & CO KGAA (DE) | 2016-12-28 | — | — | EP | claimed |
| CN-118019517-A | Sun protection or daily care composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine and an inorganic UV filter | 巴斯夫欧洲公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-113710329-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117396187-A | Composition for administration in a body cavity comprising cannabidiol | 融实医药(海南)有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-112135668-B | Oral care compositions comprising metal ions | 宝洁公司 | 2024-01-02 | — | — | CN | disclosed |
| US-11793742-B2 | Mixtures of cosmetic UV absorbers | BASF SE (DE) | 2023-10-24 | — | — | US | disclosed |
| CN-116075291-A | Method for preventing or reducing hair from falling | 联合利华知识产权控股有限公司 | 2023-05-05 | — | — | CN | disclosed |
| EP-3191075-B1 | MIXTURES OF COSMETIC UV ABSORBERS | BASF SE (DE) | 2023-02-15 | — | — | EP | disclosed |
| EP-3523350-B1 | ULTRAVIOLET RADIATION ABSORBING POLYMER COMPOSITION | BASF SE (DE) | 2022-12-07 | — | — | EP | disclosed |
| CN-115227593-A | Sunscreen formulations optimized for vitamin D formation | 巴斯夫欧洲公司 | 2022-10-25 | — | — | CN | disclosed |
| WO-2006040048-A1 | ACIDIC AND BUFFERED SKIN-CARE COMPOSITIONS COMPRISING NICOTINAMID AND AN ABSORBING AGENT | BAYER CONSUMER CARE AG (CH) | 2006-04-20 | — | — | WO | disclosed |
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | CIBA SPECIALTY CHEMICALS CORP. | 2005-03-17 | — | — | US | disclosed |
| WO-2005013931-A1 | USE OF HALOGENATED HYDROXYDIPHENYL ETHER COMPOUNDS FOR THE TREATMENT OF THE SKIN | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-02-17 | — | — | WO | disclosed |
| US-20040265248-A1 | Biphenylene compounds | CIBA SPECIALTY CHEMICALS CORP. | 2004-12-30 | — | — | US | disclosed |
| US-20040242579-A1 | Triazine derivatives and their use as sunscreens | CIBA SPECIALTY CHEMICALS CORP. | 2004-12-02 | — | — | US | disclosed |
| EP-1432400-A1 | USE OF GUAIOL FOR TREATING THE SKIN | Ciba SC Holding AG (CH) | 2004-06-30 | — | — | EP | disclosed |
| EP-1417886-A1 | Substituted phenols as useful repellents for insects | Ciba SC Holding AG (CH) | 2004-05-12 | — | — | EP | disclosed |
| EP-1378231-A1 | Formulation of UV absorbers by incorporation in solid lipid nanoparticles | Ciba Specialty Chemicals Holding Inc. (CH) | 2004-01-07 | — | — | EP | disclosed |
| US-20030235540-A1 | Formulation of UV absorbers by incorporation in solid lipid nanoparticles | CIBA SPECIALTY CHEMICALS CORP. | 2003-12-25 | — | — | US | disclosed |
| WO-2003024417-A1 | USE OF GUAIOL FOR TREATING THE SKIN | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030235540-A1 | Formulation of UV absorbers by incorporation in solid lipid nanoparticles | CUTA, LIPC, AUP1 | ACACB 38/4885ACACA 114/4885ARG2 2432/4885 |
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | TYR, MC1R, UNG | ACACB 997/4885ACACA 1448/4885ARG2 1537/4885 |
| US-20040242579-A1 | Triazine derivatives and their use as sunscreens | CBR1, CBR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ACACB 977/4885ACACA 480/4885ARG2 1173/4885 |
| US-11793742-B2 | Mixtures of cosmetic UV absorbers | BTD, TMSB10, TH | ACACB 3450/4885ACACA 4092/4885ARG2 4729/4885 |
| US-20040265248-A1 | Biphenylene compounds | AHR, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ACACB 1583/4885ACACA 1051/4885ARG2 1618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.